Penn Study Validates Effectiveness of Binary Voting in FDA Oncology Advisory Meetings

A recent investigation conducted by researchers at the University of Pennsylvania affirms that simple yes/no voting methods employed by the FDA Oncologic Drugs Advisory Committee effectively reflect the opinions of its members in the majority of instances. To view this exclusive content, please log in or subscribe. Please note: Some site licenses may not include sponsored account access. If your institution holds a site license, please log in via IP or sign up for a sponsored account.